NCT07216027View on ClinicalTrials.gov

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

August 23, 2027

Study Completion Date

August 23, 2027

Conditions
Atopic DermatitisEczema, Atopic
Interventions
DRUG

PF-08049820

Tablet

DRUG

Placebo

Tablet

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07216027 - A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema | Biotech Hunter | Biotech Hunter